 |
 |
I live 3000 miles away, and $20.00 just won't do it. Any plans to try it out further west in the future? Nancy P. >As some of you know, I have been working on a non-invasive device to >relieve PD symptoms. Our recruitment poster is now approved and I am >authorized to post it on this forum. It is essentially a tactile cueing >device that I have found effective in relieving my sympotoms. The next >stage is to determine how effective it can be for other patients. > > >Phil Gesotti 52/dx 46 >*************************************************************************** > >Volunteers with Parkinson's disease needed to test effects of a physical >device on motor symptoms >In conjunction with Lockheed Martin Corporation and NIH, doctors at the >Johns Hopkins University School of Medicine are seeking volunteer >patients with Parkinson's disease (PD) who experience "freezing" or >start hesitation to participate in a clinical trial to assess the >effects of a physical device on the motor symptoms of PD. > >Detailed ad: >PD patients needed for clinical trial of a physical device for symptoms >of PD >Volunteers are needed for a clinical trial to test whether a device, >referred to as a Transcutaneous Electrical Movement Timing Stimulator >(TEMTS), improves the motor symptoms of Parkinson's disease (PD), >including bradykinesia (slowed movements), akinesia (inability to >initiate movements), rigidity, and tremor. The TEMTS device was modeled >after a transcutaneous electrical nerve stimulation (TENS) unit, a safe >and commonly used device to treat pain symptoms. The TEMTS used in this >trial is a lightweight portable battery-operated machine (<2 pounds) >that is inserted into a pouch attached to a belt and worn around the >waist. The device provides alternating pulses of low-level stimulation >to cutaneous electrodes that are placed on the skin over a given >extremity according to the task performed. The purpose of this clinical >trial is to test the effects of the TEMTS device on quantified measures >of motor initiation, speed, tremor, and tone. > >This clinical trial will be limited to patients who experience >disruptive slowness of movement or difficulty initiating movements (also >known as "freezing" or start hesitation). In addition, participants >must be over age 20 (male or female), have a diagnosis of mild to >moderately severe PD (Hoehn and Yahr stage II-IV), be on a stable >regimen of antiparkinsonian medications, and not experience disabling >memory impairment. Subjects with a pacemaker or brain-stimulating >device are not eligible for the study. > >The study will take place at Johns Hopkins Hospital and will require >about 4 hours of testing. The testing can take place over two separate >days. Participants will be provided free parking and compensated $20 >for their time and the costs of traveling to Johns Hopkins. If you are >interested in participating, please contact Melissa Gerstenhaber, R.N., >M.S.N., Research Nurse Coordinator for the Morris K. Udall Parkinson's >Disease Research Center of Excellence at Johns Hopkins (410-614-1242) or >email her at [log in to unmask] The principal investigator of this >study is Laura Marsh, M.D.. Lockheed Martin Corporation and the >National Institutes of Health are providing financial support for the >study. > >---------------------------------------------------------------------- >To sign-off Parkinsn send a message to: mailto:[log in to unmask] >In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn